Comments

Ascendis Pharma Stock Price, Quotes and Forecasts

Q: What sector and industry does Ascendis Pharma (ASND) operate in?

Ascendis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ASNDNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$161.04

-6.95-4.14%

At close: -

$163.04

2.001.24%

After Hours: 4:52 PM EDT

Ascendis Pharma (ASND) Forecast

News Earnings Ascendis Pharma (ASND) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Ascendis Pharma Stock Price, Quotes and Forecasts | NASDAQ:ASND | Benzinga

Explore Ascendis Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ASND.

Open	$167.36
Close	$161.04
Volume / Avg.	402.86K / 459.90K
Day Range	$161.04 - $167.70
52 Wk Range	111.09 - 169.37
Market Cap	$9.80B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	59
Short Interest	7.98%
Days to Cover	8.01

Recent News

Why Is BioMarin Stock Trading Higher On Thursday?

BioMarin exceeded Q4 earnings expectations, raised 2025 guidance, and projected strong Voxzogo growth. Analysts increased price targets following the results.

Vandana Singh

Why Is Rare Disease Focused Ascendis Pharma Stock Trading Higher On Thursday?

Ascendis Pharma beat Q4 earnings and revenue estimates, driven by a $100M Novo Nordisk deal and Yorvipath's EU launch. Goldman Sachs raised its price target.

Vandana Singh

This Coca-Cola Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Jan

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$167.36
Close	$161.04
Volume / Avg.	402.86K / 459.90K
Day Range	$161.04 - $167.70
52 Wk Range	111.09 - 169.37
Market Cap	$9.80B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	59
Short Interest	7.98%
Days to Cover	8.01

About Ascendis Pharma A/S

Sector

Health Care

Industry

Biotechnology

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to m...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Ascendis Pharma (ASND) stock?

You can purchase shares of Ascendis Pharma (NASDAQ:ASND) through any online brokerage.

View our list of the best stock brokerages

Who are Ascendis Pharma (ASND) competitors?

Other companies in Ascendis Pharma’s space includes: BeiGene (NASDAQ:ONC), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for Ascendis Pharma (ASND) stock?

Ascendis Pharma has a consensus price target of $190.76.

What is the current price for Ascendis Pharma (ASND)?

The stock price for Ascendis Pharma (NASDAQ: ASND) is $163.04 last updated March 25, 2025 at 4:52 PM EDT.

Does Ascendis Pharma (ASND) pay a dividend?

There are no upcoming dividends for Ascendis Pharma.

When is Ascendis Pharma (NASDAQ:ASND) reporting earnings?

Ascendis Pharma’s Q1 earnings are confirmed for Thursday, May 1, 2025.

Is Ascendis Pharma (ASND) going to split?

There is no upcoming split for Ascendis Pharma.

What sector and industry does Ascendis Pharma (ASND) operate in?

Ascendis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.